Making Virus Inactivation a Reality for Continuous Upscaled Processes
The Cadence™ Virus Inactivation (VI) system, a fully automated low pH virus inactivation system for both batch and continuous processing is one of the latest additions to Pall’s Continuous platform. This webinar will discuss how traditional low pH virus inactivation has been translated into an automatic system, and also the additional challenges associated with making it a continuous process. There will be a review of the two methods used for validating the design and an overview of the integration of capture chromatography and virus inactivation, which represents the first commercial scale combined unit operations in this space.
Moderator
Speakers
Mark Schofield, Ph.D.
Principal R&D Engineer
Pall
Biography
Biotech | Pall Corporation webinar series
Meet the authors from the ‘Insights on Successful Gene Therapy Manufacturing and Commercialization’ ebook